MiMedx Group, Inc. was a big mover last session, as its shares rose above 8% on the day. The move came after the company’s first-quarter 2017 revenue performance exceeded the top end of its guidance, especially in light of the traditional seasonality impact that the market experiences during this time of the year. This also led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 27% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Thursday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

MiMedx Group currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

MiMedx Group, Inc Price

 

MiMedx Group, Inc Price | MiMedx Group, Inc Quote

A better-ranked ranked stock in the Medical – Biomedical and Genetics space is Heska Corporation , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is MDXG going up? Or down? Predict to see what others think: Up or Down
    

The Best & Worst of Zacks

Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>